Frontlight ResearchEarly access
Childhood cancers trials in United States
932 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleTesting the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
- Where
- Boston, Houston, Los Angeles, Pittsburgh
- Age
- 12 years and over
- People
- 36
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05019716 - Phase 2Taking peopleTesting Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
- Where
- Bethesda, Columbus, Hartford, Houston, Los Angeles, New Haven, Oklahoma City, Pittsburgh, Trumbull, Washington D.C.
- Age
- 12 years and over
- People
- 27
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05333458 - Phase 1Taking peopleTesting the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
- Where
- Boston, Houston, Los Angeles, Newport Beach, Pittsburgh
- Age
- 12 years and over
- People
- 45
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05372640 - Phase 2Taking peopleTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Where
- Abilene, ‘Aiea, Albuquerque, Allentown, Altoona, Anaconda, Anchorage, Ankeny, Ann Arbor, Appleton, Arroyo Grande, Asheboro, Ashland, Athens, Augusta, Aurora, Aventura, Avon, Baltimore, Barrington, Battle Creek, Beachwood, Bellevue, Belpre, Bemidji, Berlin, Bethesda, Bethlehem, Billings, Birmingham, Bismarck, Bloomington, Boiling Springs, Boise, Boston, Bozeman, Brewer, Brighton, Bristol, Bryn Mawr, Buffalo, Burlington, Caldwell, Canton, Cape Girardeau, Carmichael, Carterville, Carthage, Cedar Rapids, Centerville, Centralia, Charleston, Charlottesville, Chelsea, Chesterfield, Chicago, Chillicothe, Cincinnati, City of Saint Peters, Cleveland, Clinton, Coeur d'Alene, Collierville, Columbia, Columbus, Commack, Coon Rapids, Coral Gables, Creve Coeur, Crown Point, Crystal Lake, Cumberland, Dallas, Danville, Dayton, Dearborn, Decatur, Deerfield Beach, Deer River, DeKalb, Delaware, Des Moines, Dixon, Downers Grove, Dublin, Duluth, Durham, Easley, East Stroudsburg, Eau Claire, Edina, Edmonds, Effingham, Elgin, Elk Grove, Encinitas, Erie, Escanaba, Eureka, Evanston, ‘Ewa Beach, Fairfax, Falls Church, Fargo, Farmington, Farmington Hills, Findlay, Flemington, Flint, Fort Collins, Fort Lauderdale, Franklin, Fruitland, Gainesville, Galesburg, Geneva, Germantown, Glenview, Goldsboro, Goodyear, Grafton, Grand Rapids, Grayslake, Great Falls, Greeley, Green Bay, Greensboro, Greensburg, Greenville, Greer, Grenada, Grove City, Gulfport, Harrison, Harvey, Hazel Crest, Hazleton, Hibbing, Highland Park, High Point, Honolulu, Houston, Huntington, Issaquah, Jacksonville, Janesville, Johnson City, Jonesboro, Kalamazoo, Kalispell, Kenosha, Kettering, Kewanee, Kingman, Kingsport, Lacey, La Crosse, La Jolla, Lake Forest, Lakewood, Lancaster, Lansing, Las Vegas, Lexington, Libertyville, Livingston, Livonia, Long Branch, Los Angeles, Loveland, Lubbock, Macomb, Madison, Manistique, Mansfield, Maple Grove, Maplewood, Marinette, Marion, Marshfield, Martinez, Marysville, Mattoon, Mayfield Heights, Maywood, Mechanicsburg, Media, Memphis, Mentor, Meridian, Metairie, Miami, Michigan City, Middleburg Heights, Middletown, Milwaukee, Mineola, Minneapolis, Minocqua, Missoula, Mobile, Monroeville, Morgantown, Mount Vernon, Mukwonago, Muskegon, Nampa, Nashville, Nassau Bay, Neenah, New Albany, Newark, Newberg, New Brunswick, New Lenox, New London, Newnan, New Orleans, New Richmond, New York, Niles, Normal, North Miami, Norton Shores, Oak Lawn, Oconomowoc, Oconto Falls, O'Fallon, Oklahoma City, Omaha, Ontario, Orange, Oregon City, Orland Park, Oshkosh, Ottawa, Oxford, Paducah, Palo Alto, Paoli, Park Ridge, Pekin, Pennington, Peoria, Perrysburg, Peru, Philadelphia, Phoenix, Pickerington, Pittsburgh, Plantation, Pontiac, Portland, Portsmouth, Post Falls, Princeton, Providence, Racine, Raleigh, Rapid City, Reed City, Reidsville, Reno, Renton, Rice Lake, Richmond, Roanoke, Rochester, Rockford, Rocklin, Rolla, Royal Oak, Sacramento, Saginaw, Sainte Genevieve, Saint Joseph, Saint Louis Park, Saint Paul, San Diego, Sandpoint, Sandstone, San Francisco, Santa Monica, Sayre, Scarborough, Seattle, Seneca, Sewell, Shawano, Sheboygan, Shiloh, Sioux Falls, Somerville, South Bend, Southhaven, South Hill, South Portland, Springfield, Stevens Point, St Louis, Stoneham, Sturgeon Bay, Sugar Land, Sullivan, Summit, Syracuse, Tawas City, Temple, The Bronx, The Woodlands, Toledo, Toms River, Traverse City, Troy, Twin Falls, Two Rivers, Urbana, Virginia, Walla Walla, Walnut Creek, Warrenville, Washington, Waukee, Waukesha, Waupaca, Wauwatosa, West Allis, West Branch, Westerville, Weston, Whittier, Willow Grove, Winston-Salem, Woodland, Wynnewood, Wyoming, Yakima, Youngstown, Ypsilanti, Zanesville, Zion
- People
- 2,900 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05564377 - Phase 3Taking peopleA Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Where
- Akron, Albany, Albuquerque, Allentown, Anchorage, Ankeny, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baker City, Baltimore, Bangor, Barrington, Bath, Battle Creek, Bellevue, Bethesda, Birmingham, Boiling Springs, Boise, Boston, Brighton, Brownstown, Buffalo, Burlington, Caldwell, Camden, Camillus, Canton, Cape Girardeau, Carmichael, Carroll, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chelsea, Chesterfield, Chicago, Cincinnati, City of Saint Peters, Cleveland, Clinton Township, Clive, Colorado Springs, Columbia, Columbus, Coon Rapids, Corona, Corpus Christi, Costa Mesa, Creve Coeur, Crystal Lake, Cudahy, Dallas, Danville, Dayton, Dearborn, Decatur, DeKalb, Denver, Derby, Des Moines, Detroit, Downers Grove, Downey, Duarte, Dublin, Durham, East Lansing, East Syracuse, Edina, Effingham, Elgin, Elizabeth, Elk Grove, Elmhurst, El Paso, Evanston, Fairfield, Falls Church, Fargo, Farmington Hills, Flemington, Fort Collins, Fort Lauderdale, Fort Myers, Fort Worth, Fremont, Fresno, Fruitland, Gainesville, Geneva, Germantown, Glastonbury, Glens Falls, Glenview, Goodyear, Grafton, Grand Rapids, Grayslake, Greeley, Green Bay, Greenville, Greenwich, Guilford, Hackensack, Hartford, Hazel Crest, Hershey, Highland Park, Hollywood, Honolulu, Houston, Huntington, Huntington Beach, Indianapolis, Iowa City, Irvine, Jackson, Jacksonville, Jersey City, Kalamazoo, Kansas City, Kenosha, Knoxville, La Crosse, Lake Forest, Lancaster, Las Vegas, Lebanon, Lexington, Libertyville, Little Rock, Livingston, Livonia, Loma Linda, Long Beach, Long Branch, Los Angeles, Louisville, Loveland, Lubbock, Macomb, Macon, Madera, Madison, Marinette, Marshfield, Mattoon, Maywood, Meridian, Mesa, Miami, Miami Beach, Milwaukee, Mineola, Minneapolis, Mobile, Modesto, Morristown, Mukwonago, Muskegon, Nampa, Naperville, Nashville, Neptune City, Newark, Newberg, New Brunswick, New Haven, New Hyde Park, New Orleans, Newport Beach, New York, Norfolk, North Haven, Norton Shores, Novi, Oakland, Oak Lawn, Oconomowoc, O'Fallon, Oklahoma City, Omaha, Ontario, Orange, Oregon City, Orlando, Orland Park, Oshkosh, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Plainfield, Pontiac, Portland, Portsmouth, Providence, Racine, Reed City, Reno, Renton, Richmond, Roanoke, Rochester, Rockford, Rocklin, Royal Oak, Sacramento, Saint Joseph, Saint Louis Park, Saint Paul, Salt Lake City, San Antonio, San Diego, Sanford, San Francisco, San Jose, San Leandro, San Rafael, Santa Barbara, Santa Rosa, Savannah, Scarborough, Seattle, Seneca, Sheboygan, Shiloh, Sioux Falls, Southfield, South Pasadena, South Portland, South San Francisco, Spokane, Springfield, Stamford, St Louis, Stony Brook, St. Petersburg, Sturgeon Bay, Summit, Syracuse, Tacoma, Tampa, Temple, The Bronx, Toledo, Toms River, Torrance, Torrington, Traverse City, Troy, Trumbull, Tulsa, Twin Falls, Two Rivers, Upland, Urbana, Vallejo, Walnut Creek, Warrenville, Washington D.C., Waterbury, Waterford, Waukee, Waukesha, Wauwatosa, Webster, West Allis, West Bloomfield, Westerly, West Palm Beach, Wichita, Williamsville, Wilmington, Winston-Salem, Woodbury, Woodland, Worcester, Wyandotte, Wyoming, Yorkville, Ypsilanti
- Age
- 5 years to 60 years
- People
- 1,875 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05675410 - Phase 1/2Taking peopleTINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Where
- Charlotte, Hershey, Houston, Little Rock, Los Angeles, Madera, Minneapolis, New York, Norfolk, Orange, Orlando, Palo Alto, Phoenix, Portland, Salt Lake City, San Antonio, San Diego
- Age
- Up to 1 year
- People
- 90 worldwide
- Run by
- Tanja Andrea Gruber
See details and how to joinNCT05848687 - Phase 1Taking peopleSafety and Feasibility of Intraoperative Visualization With Cytalux in Children
- Where
- Chicago
- Age
- 6 years to 17 years
- People
- 10
- Run by
- Ann & Robert H Lurie Children's Hospital of Chicago
See details and how to joinNCT06235125 - No phaseTaking peopleGenerating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
- Where
- Buffalo, Columbus, Hartford, Lexington, Miami, Tampa
- People
- 35
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06423950 - Phase 2Taking peoplePhase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
- Where
- Houston
- Age
- 12 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06444880 - Phase 1/2Taking peopleSilmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Where
- Birmingham, Charleston, Dallas, Detroit, Gainesville, Hackensack, Hartford, Hershey, Honolulu, Kansas City, Louisville, Miami, Milwaukee, Nashville, Oakland, Orlando, Phoenix, Providence, Richmond, Sacramento, Salt Lake City, San Diego, St Louis, St. Petersburg, Tampa
- Age
- Up to 30 years
- People
- 104 worldwide
- Run by
- Milton S. Hershey Medical Center
See details and how to joinNCT06541262 - Phase 1/2Taking peopleTrial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
- Where
- Albuquerque, Atlanta, Boston, Buffalo, Cleveland, Dallas, Detroit, Houston, Indianapolis, Irvine, Jacksonville, Longmont, New York, Norfolk, Omaha, Philadelphia, Phoenix, Pittsburgh, Rochester, Salt Lake City, San Diego, Santa Monica, Seattle, St Louis
- People
- 64 worldwide
- Run by
- RayzeBio, Inc.
See details and how to joinNCT06590857 - Phase 1Taking peopleA Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- Where
- Boston, Duarte, Houston, Newport Beach, New York
- Age
- 16 years and over
- People
- 171
- Run by
- SEED Therapeutics, Inc.
See details and how to joinNCT07197554 - Phase 3Taking peopleA Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
- Where
- Cincinnati, Houston, Memphis, New York, Philadelphia
- Age
- 1 year to 64 years
- People
- 130 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07223021 · EU 2025-523096-34-00 - No phaseTaking peopleA Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
- Where
- Detroit
- People
- 160
- Run by
- Henry Ford Health System
See details and how to joinNCT07348367 - Phase 1Not yet taking people in United StatesAutologous iC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma
- Where
- Houston
- Age
- 16 years to 75 years
- People
- 21
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT07729397 - No phaseTaking peopleHereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
- Where
- Bethesda
- Age
- 2 years and over
- People
- 1,350
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00050752 - No phaseTaking peopleEvaluation and Treatment of Neurosurgical Disorders
- Where
- Bethesda
- Age
- 4 years to 99 years
- People
- 5,000
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT00060541 - No phaseEnrolling by invitationCollection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
- Where
- Bethesda
- Age
- 2 years and over
- People
- 100
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02154022 - No phaseTaking peopleStudies of Dermatologic Diseases Biospecimen Acquisition Protocol
- Where
- Bethesda
- Age
- 1 day to 100 years
- People
- 700
- Run by
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
See details and how to joinNCT02471352 - Phase 1Taking peopleStudy of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- Where
- Houston
- Age
- 12 years to 50 years
- People
- 44
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03093909 - Phase 4Active, not recruitingDabrafenib and/or Trametinib Rollover Study
- Where
- Bethesda, Columbus, Dallas, Scottsdale
- Age
- 18 years to 100 years
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - Phase 2Taking peopleDexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
- Where
- Houston
- Age
- 12 years and over
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03589729 - Phase 1Taking peopleLET Optimized IMPT in Treating Pediatric Patients With Ependymoma
- Where
- Boston, Houston
- Age
- Up to 22 years
- People
- 48
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03750513 - Phase 2Taking peopleA Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- Where
- New York
- People
- 286
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04936529 - Phase 1/2Taking peopleThe Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
- Where
- Bethesda, Duarte
- Age
- 12 years to 120 years
- People
- 260
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05436418